You can buy or sell INNT and other stocks, options, ETFs, and crypto commission-free!
Innovate Biopharmaceuticals, Inc. Common Stock, also called Innovate Biopharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It foucs on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.
Raleigh, North Carolina
52 Week High
52 Week Low
Seeking AlphaMar 4
Innovate Biopharmaceuticals (INNT) Presnts At Conference Call to Provide Corporate and Operational Updates - Slideshow
The following slide deck was published by Innovate Biopharmaceuticals, Inc. in conjunction with this event. 1 32 Click to enlarge Notes:...
Stock Price, News, & Analysis for Innovate Biopharmaceuticals
Innovate Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company's lead product candidate is INN-202 that has completed Phase 2b clinical trial for the treatment of celiac disease. It also develops INN-108, which has completed Phase 1 clinical trial to treat mild-to-moderate ulcerative colitis; INN-217 for the treatment of non-alcoholic steatohepatitis and microbiome; and INN-289 to treat crohn's disease. In addition, the...
Simply Wall StFeb 16
Do Directors Own Innovate Biopharmaceuticals, Inc. (NASDAQ:INNT) Shares?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! A look at the shareholders of Innovate Biopharmaceuticals, Inc. (NASDAQ:INNT) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, ‘Don’t tell me wh...
-$0.11 per share